UNITY Biotechnology, Inc.
UNBX Healthcare Biotechnology
UNITY Biotechnology, Inc.’s revenue for fiscal 2022 (year ended December 2022) was $236,000.00. In the quarter to March 2025, EPS fell 26.5% and free cash flow fell 23.1%, each against the same quarter a year earlier. Operating cash flow growth for three consecutive years.
Follow UNBX
A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.
| Mar '25 | Dec '24 | Sep '24 | Jun '24 | Older periods | |
|---|---|---|---|---|---|
Cash and Short Term Investments |
16.93 | 23.23 | 29.04 | 33.98 |
+8 more quarters Free account |
Total current assets |
17.65 | 24.27 | 30.26 | 35.85 | |
Property, Plant, Equpment (Net) |
3.28 | 3.46 | 4.41 | 4.63 | |
Long-term assets (Other) |
0.97 | 1.04 | 1.10 | 1.15 | |
Total non-current assets |
12.70 | 13.40 | 16.87 | 17.68 | |
Total Assets |
30.35 | 37.66 | 47.13 | 53.52 | |
Accounts Payable |
1.76 | 1.00 | 1.80 | 1.46 | |
Total current liabilities |
9.07 | 9.26 | 8.78 | 8.82 | |
Non-current Liabilities (Other) |
2.81 | 2.20 | 3.51 | 3.29 | |
Total non-current liabilities |
21.49 | 21.91 | 24.20 | 24.95 | |
Total liabilities |
30.55 | 31.17 | 32.99 | 33.77 | |
Additional Paid In Capital |
517.44 | 516.82 | 516.01 | 515.21 | |
Common Stock (Net) |
0.00 | 0.00 | 0.00 | 0.00 | |
Retained Earnings |
(517.64) | (510.34) | (501.90) | (495.42) | |
Common Equity (Total) |
(0.20) | 6.49 | 14.14 | 19.75 | |
Shareholders Equity (Total) |
(0.20) | 6.49 | 14.14 | 19.75 | |
Shareholders Equity and Liabilities (Total) |
30.35 | 37.66 | 47.13 | 53.52 | |
Shares (Common) |
17.21 | 16.87 | 16.85 | 16.85 | |
Shareholders Equity (Tangible) |
(0.20) | 6.49 | 14.14 | 19.75 | |
Net Debt |
(16.93) | (23.23) | (29.04) | (33.98) |